These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21786142)

  • 41. Molecular Basis of Cystinosis: Geographic Distribution, Functional Consequences of Mutations in the CTNS Gene, and Potential for Repair.
    David D; Princiero Berlingerio S; Elmonem MA; Oliveira Arcolino F; Soliman N; van den Heuvel B; Gijsbers R; Levtchenko E
    Nephron; 2019; 141(2):133-146. PubMed ID: 30554218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction.
    Elmonem MA; Khalil R; Khodaparast L; Khodaparast L; Arcolino FO; Morgan J; Pastore A; Tylzanowski P; Ny A; Lowe M; de Witte PA; Baelde HJ; van den Heuvel LP; Levtchenko E
    Sci Rep; 2017 Feb; 7():42583. PubMed ID: 28198397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.
    Servais A; Morinière V; Grünfeld JP; Noël LH; Goujon JM; Chadefaux-Vekemans B; Antignac C
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):27-35. PubMed ID: 18178779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural history of adolescent-onset cystinosis.
    Midgley JP; El-Kares R; Mathieu F; Goodyer P
    Pediatr Nephrol; 2011 Aug; 26(8):1335-7. PubMed ID: 21553323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The first molecular genetics analysis of individuals suffering from nephropatic cystinosis in the Southwestern Iran.
    Shahkarami S; Galehdari H; Ahmadzadeh A; Babaahmadi M; Pedram M
    Nefrologia; 2013; 33(3):308-15. PubMed ID: 23640116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cystinosis induced by
    Wang X; Zhang BL; Chen XY; Guo Z
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec; 23(12):1276-1281. PubMed ID: 34911613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Analysis of the CTNS Gene in Indians with Nephropathic Cystinosis.
    Deshpande AA; Ravichandran R; Bachhawat AK
    Indian J Pediatr; 2017 Mar; 84(3):240-241. PubMed ID: 27885487
    [No Abstract]   [Full Text] [Related]  

  • 49. Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.
    Fleige T; Burggraf S; Czibere L; Häring J; Glück B; Keitel LM; Landt O; Harms E; Hohenfellner K; Durner J; Röschinger W; Becker M
    Eur J Hum Genet; 2020 Feb; 28(2):193-201. PubMed ID: 31570786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
    Gahl WA; Balog JZ; Kleta R
    Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis.
    Topaloglu R; Gulhan B; İnözü M; Canpolat N; Yilmaz A; Noyan A; Dursun İ; Gökçe İ; Gürgöze MK; Akinci N; Baskin E; Serdaroğlu E; Demircioğlu Kiliç B; Yüksel S; Övünç Hacihamdioğlu D; Korkmaz E; Hayran M; Ozaltin F;
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1634-1641. PubMed ID: 28793998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis.
    Cherqui S; Sevin C; Hamard G; Kalatzis V; Sich M; Pequignot MO; Gogat K; Abitbol M; Broyer M; Gubler MC; Antignac C
    Mol Cell Biol; 2002 Nov; 22(21):7622-32. PubMed ID: 12370309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
    Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
    Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutational spectrum of the CTNS gene in Italy.
    Mason S; Pepe G; Dall'Amico R; Tartaglia S; Casciani S; Greco M; Bencivenga P; Murer L; Rizzoni G; Tenconi R; Clementi M
    Eur J Hum Genet; 2003 Jul; 11(7):503-8. PubMed ID: 12825071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis.
    Krohn P; Rega LR; Harvent M; Festa BP; Taranta A; Luciani A; Dewulf J; Cremonesi A; Camassei FD; Hanson JVM; Gerth-Kahlert C; Emma F; Berquez M; Devuyst O
    Hum Mol Genet; 2022 Jul; 31(13):2262-2278. PubMed ID: 35137071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis.
    Jamalpoor A; Othman A; Levtchenko EN; Masereeuw R; Janssen MJ
    Trends Mol Med; 2021 Jul; 27(7):673-686. PubMed ID: 33975805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
    Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
    BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
    Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
    J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility.
    Ivanova EA; Arcolino FO; Elmonem MA; Rastaldi MP; Giardino L; Cornelissen EM; van den Heuvel LP; Levtchenko EN
    Kidney Int; 2016 May; 89(5):1037-1048. PubMed ID: 27083281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.